Home / NIH / Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) / Notice

Preclinical Medications Discovery and Abuse Liability Testing for NIDA

Updated

Presolicitation from the National Institutes of Health, for work in Bethesda, Maryland. Due Nov 27, 2026, 1:00 PM (UTC-5), 13 days left.

Be among the first to see new Research and Development in the Physical, Engineering, and Life Sciences contracts
Only new notices that match, once a day.
Solicitation number75N95022C00004
AgencyNational Institutes of Health
OfficeNational Institutes of Health Olao
Notice typePresolicitation
Set-asideNone
Trade (NAICS)Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
Product or service codeAN11
Place of performanceBethesda, Maryland
PostedNov 13, 2026
Response deadlineNov 27, 2026, 1:00 PM (UTC-5) (13 days left)
Add the deadline toGoogle Calendar · Apple / Outlook (.ics)
Official notice
Send to a teammate

Federal prevailing wage rates for this place: Maryland Davis-Bacon and SCA wage determinations.

Description

Notice of a proposed contract action non-competitive Notice id: 75N95022C00004 Contract Opportunity Type: Presolicitation Response Date: November 27, 2026, at 1:00 PM Eastern Time (15 days) Classification: No Small Business Set Aside Used Product Service Code: AN11 NAICS Code: 541715 Place of Performance: Blank Description PURSUANT TO RFO 5.101 — PRESOLICITATION NOTICE, THIS IS A NOTICE OF A PROPOSED CONTRACT ACTION.

This is a notice of intent to award a sole source modification under contract no. 75N95022C00004 with Virginia commonwealth university. This is not a solicitation or a request for competitive proposals.

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), through the Addiction Treatment Discovery Program (ATDP) within NIDA’s Division of Therapeutics and Medical Consequences (DTMC), intends to modify Single Award Contract No. 75N95022C00004, “Preclinical Medications Discovery and Abuse Liability Testing for NIDA,” to extend the period of performance by 12-months through February 21, 2027.

All other terms and conditions remain unchanged. This modification will allow for the continuation of ongoing research conducted under the Preclinical Medications Discovery and Abuse Liability Testing program for NIDA and prevent any delays or disruption to the development of therapeutics essential for ongoing and upcoming pre-clinical and clinical trials while a new contract is properly planned and competed.

REGULATORY AUTHORITY The resultant modification will include all applicable provisions and clauses of the Revolutionary FAR Overhaul (RFO) Initiative, in accordance with Executive Order 14275 and OMB Memorandum M-25-26. STATUTORY AUTHORITY This modification is conducted under the authority of 41 U.S.C. 3304(a)(1) and in accordance with RFO 6.103-1 Only one responsible source and no other supplies or services will satisfy agency requirements.

Closing statement this is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government.

All responsible sources may submit a capability statement, proposal, or quotation which shall be considered by the agency. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size.

All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All responses must be received by the closing date and time of this announcement and must reference the Project Title, “Preclinical Medications Discovery and Abuse Liability Testing for NIDA.”

Responses must be submitted electronically to Shayna Simpson, Contracting Officer, at [email protected]. Mailed and faxed responses will not be accepted. PRIMARY POINT OF CONTACT: Shayna Simpson Email: [email protected] Phone: 301-402-9712

Contracting contact

As published on the official notice. Ask questions in writing and before any questions deadline the notice sets.

Is your business small enough?

For NAICS 541715, a business counts as small if it has no more than 11 employees (SBA size standard, with exceptions in the notes). This notice is not set aside, but the size decides your small business status on it. SBA table, current as of Oct 15, 2026.

Companies that win this kind of work

Federal contractors paid for research and development in the physical, engineering, and life sciences work, who also hold NIH contracts (last 12 months): possible competitors, or partners to team with.

About the buyer

The National Institutes of Health awarded $5.9 billion in contracts in the last 12 months; its biggest suppliers were Leidos Biomedical Research Inc, M. A. Mortenson Company and Deloitte Consulting LLP. See what NIH is buying now.

Research and Development in the Physical, Engineering, and Life Sciences contracts right now

There are 280 open government contract opportunities in this trade (NAICS 541715), 46 posted in the last 7 days; 30% are set aside for small businesses. The agencies buying the most are Department of the Air Force, Department of the Army and National Institutes of Health. Most of the work with a stated place is in Maryland, District of Columbia and Virginia. A notice in this trade gives a median of 46 days from posting to deadline; this one gives 14 days.

All open research and development in the physical, engineering, and life sciences contracts

Coming up in this trade

Planned contracts from the agencies' procurement forecasts, often months before a solicitation. Plans can change.

Replicable, Actionable Projects for Intelligent Transportation Systems (ITS) Deployment, Broad Agency Announcement (RAPID BAA)
Federal Highway Administration
$250M - $499M · Unrestricted · Combination
Detect Soil Drainage Using Electrical Resistivity Imaging Technique
Federal Railroad Administration
$500K - $999K · To Be Determined
Wayside Detector Technology Best Practices Phase 4
Federal Railroad Administration
$500K - $999K · To Be Determined

Recent awards in this trade

From the award notices agencies publish.

Similar open research and development in the physical, engineering, and life sciences bids

Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Defense Health Agency (DHA)
Due Nov 20, 2026, 12:00 PM (UTC-5) · 6 days left
Solicitation · Frederick, MD · Posted Nov 13, 2026
Request for Information (RFI) - EmbraceHEALTH Clinical Research Network (EmbraceHEALTH CRN) - Coordinating Center
National Institutes of Health
Due Nov 17, 2026, 4:00 PM (UTC-5) · 3 days left
Special Notice · Bethesda, MD · Posted Nov 12, 2026
Request for Information (RFI) - EmbraceHEALTH Clinical Research Network (EmbraceHEALTH CRN)
National Institutes of Health
Due Nov 17, 2026, 4:00 PM (UTC-5) · 3 days left
Special Notice · Bethesda, MD · Posted Nov 12, 2026
SAFE-PLASMA Protocol
Defense Health Agency (DHA)
Due Nov 16, 2026, 2:00 PM (UTC-5) · 2 days left
Sources Sought · MD · Posted Nov 10, 2026
EmbraceHEALTH Clinical Research Network (EmbraceHEALTH CRN) - Coordinating Center
National Institutes of Health
Due Nov 23, 2026, 4:00 PM (UTC-5) · 9 days left
Sources Sought · Bethesda, MD · Posted Nov 6, 2026
EmbraceHEALTH Clinical Research Network (EmbraceHEALTH CRN)
National Institutes of Health
Due Nov 19, 2026, 4:00 PM (UTC-5) · 5 days left
Sources Sought · Bethesda, MD · Posted Nov 4, 2026